
DiaMedica Therapeutics
Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases.
About
DiaMedica Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies that reduce ischemia for patients with serious vascular diseases. Their initial focus is on preeclampsia, fetal growth restriction, and acute ischemic stroke, aiming to reverse ischemic injury and improve patient outcomes. The company is advancing patient care through a novel approach with their lead drug candidate, DM199.
Similar companies
A clinical-stage biotechnology company developing in vivo gene editing therapies.
Shares Biotechnology, Pharmaceuticals
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Biotechnology, Pharmaceuticals
Biotechnology company focused on developing cancer immunotherapies.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Shares Biotechnology, Pharmaceuticals
Developing novel therapeutics to restore gut lymphatic function.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- diamedica.com
- Headquarters
- Minneapolis, United States
- Founded
- 2000
- Total funding
- $30M (Private Placement)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 21 Jul 2025 | Private Placement | $30M |
Tech stack
Detected on diamedica.com, last scanned 22 Sept 2026. Run your own scan
- Frontend
- Bootstrap
- Analytics
- Google Analytics 4
- Hosting
- AWS
DiaMedica Therapeutics scores 35. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is DiaMedica Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for DiaMedica Therapeutics is 90 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has DiaMedica Therapeutics raised?
DiaMedica Therapeutics has raised a total of $30M in funding. The most recent round on record is Private Placement.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for DiaMedica Therapeutics


